ESG Investor Education Event (Clinical Trial Diversity)

During the 45 minute session Alberto Fernandez, SVP of Global Clinical Operations at GSK and Dr. Kimberly Smith, SVP and Head of R&D at ViiV Healthcare, provided insights on the importance of clinical trial diversity including support from a 17-year retrospective study. During the session, the leaders also provided an overview of GSK’s work to ensure clinical trials reflect the populations most impacted by a disease and explored a HIV case study that demonstrated the power of clinical trial diversity in action. The presentation was followed by an opportunity for audience Q&A.